Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in MAIA — MAIA Biotechnology, Inc.

CIK 1214717 BOSTON, MA
Back to MAIA Full portfolio

Position in MAIA

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$726,307
+$221,634 QoQ
Shares Held
504,380
+39.9% QoQ
Ownership
0.829%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 36 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MAIA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. MAIA ranks #339 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in MAIA

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $726,307 504,380
2026-03-31 $504,673 360,481
2025-12-31 $454,012 296,740
2025-09-30 $417,425 271,056
2025-06-30 $399,928 222,183
2025-03-31 $328,087 214,437
2024-12-31 $391,097 197,524
2024-09-30 $541,101 192,563
2024-06-30 $536,056 156,742
2024-03-31 $117,165 53,257
2023-12-31 $52,131 44,557
2023-09-30 $98,025 44,557
2023-06-30 $74,771 33,987